wn 11 research area · establishment of west nile virus -neutralizing human monoclonal antibodies...

1
Establishment of West Nile virus -neutralizing human monoclonal antibodies derived from the individuals vaccinated with inactivated Japanese encephalitis virus by ISAAC technology. 16th International Congress of Immunology (ICI2016), August 2016, Melbourne, Australia. 1. 新奇ウエストナイルウイルス(WNV)ワクチンの開発 2. WNVに対する抗体医薬の開発 3. 新奇チクングニアウイルスワクチンの開発 4. 新奇ジカウイルスワクチンの開発 Recent Activities Research Area アルボウイルス感染症に対する新奇ワクチンの開発 (准教授・正木秀幸, [email protected]) WNVに対する抗体の感染防御効果 0 20 40 60 80 100 1 3 5 7 9 11 13 15 17 19 21 23 25 Day post WNV inoculation Survival rate (%) WN_11 WN_39 WN_83 isotype control P=0.018 IFNγ - detecting ELISPOT assay in response to WNV CTL epitope peptide

Upload: others

Post on 17-Aug-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: WN 11 Research Area · Establishment of West Nile virus -neutralizing human monoclonal antibodies derived from the individuals vaccinated with inactivated Japanese encephalitis virus

Establishment of West Nile virus -neutralizing human monoclonal antibodies derived from the

individuals vaccinated with inactivated Japanese encephalitis virus by ISAAC technology. 16th

International Congress of Immunology (ICI2016), August 2016, Melbourne, Australia.

1. 新奇ウエストナイルウイルス(WNV)ワクチンの開発 2. WNVに対する抗体医薬の開発 3. 新奇チクングニアウイルスワクチンの開発 4. 新奇ジカウイルスワクチンの開発

Recent Activities

Research Area

アルボウイルス感染症に対する新奇ワクチンの開発 (准教授・正木秀幸, [email protected])

WNVに対する抗体の感染防御効果

0

20

40

60

80

100

1 3 5 7 9 11 13 15 17 19 21 23 25

Day post WNV inoculation

Surviv

al

rate (

%) WN_11

WN_39

WN_83

isotype control

P=0.018

IFNγ - detecting ELISPOT assay in response to

WNV CTL epitope peptide